Literature DB >> 20230328

Treatment with teriparatide in a patient with pregnancy-associated osteoporosis.

Lars Hellmeyer1, Jelena Boekhoff, Peyman Hadji.   

Abstract

INTRODUCTION: The decrease of BMD during a physiological pregnancy can in rare cases be intensified and lead to dramatic microarchitectural changes, which causes an increase incidence of fractures, preferably at the spine. This dramatic clinical picture is called pregnancy-associated osteoporosis. CASE HISTORY: We present the case of a 40-year-old woman (gravida IV, para II) with acute back pain right after delivery due to four fractures of the spine. The diagnosis was confirmed by dual-energy X-ray absorptiometry measurement result (T-score -4.1 SD (0.598 g/cm(2)) at the lumbar spine (L1-L4), T-score -1.5 SD (0.759 g/cm(2)) at the total hip). Due to the severity of symptoms, a therapy with teriparatide (20 mg daily) was started for a period of 18 months.
RESULTS: After end of therapy, the T-score had significantly increased at the lumbar spine as well as at the hip (T-score of -2.1 (0.813 g/cm(2)) and -0.6 (0.864 g/cm(2)), respectively. The relative increase of BMD at the spine and total hip was 36% and 13.8%, respectively. DISCUSSION: Our report demonstrates the successful use of teriparatide underlined by the increase of bone mineral density and the improvement of clinical symptoms in a case of severe pregnancy-associated osteoporosis for the first time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230328     DOI: 10.3109/09513591003649831

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  13 in total

Review 1.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

2.  Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life.

Authors:  Martin Gehlen; Ana Doina Lazarescu; Christian Hinz; Michael Schwarz-Eywill; Michael Pfeifer; Subathira Balasingam; Anna Maier
Journal:  Clin Rheumatol       Date:  2019-08-29       Impact factor: 2.980

3.  Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate.

Authors:  Guido Zarattini; Pierangelo Buffoli; Giuliana Isabelli; Marcella Marchese
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

4.  Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.

Authors:  Lu-Jiao Li; Jia Zhang; Peng Gao; Fang Lv; Yu-Wen Song; Xiao-Yan Chang; Di-Chen Zhao; Ou Wang; Yan Jiang; Xiao-Ping Xing; Wei-Bo Xia; Mei Li
Journal:  Clin Rheumatol       Date:  2018-06-26       Impact factor: 2.980

5.  Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.

Authors:  Eun Yeong Choe; Je Eun Song; Kyeong Hye Park; Hannah Seok; Eun Jig Lee; Sung-Kil Lim; Yumie Rhee
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

Review 6.  Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.

Authors:  M Laroche; M Talibart; C Cormier; C Roux; P Guggenbuhl; Y Degboe
Journal:  Osteoporos Int       Date:  2017-09-06       Impact factor: 4.507

7.  Pregnancy-associated osteoporosis: a case-control study.

Authors:  P Hadji; J Boekhoff; M Hahn; L Hellmeyer; O Hars; I Kyvernitakis
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

8.  Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level.

Authors:  Adi Cohen; Mafo Kamanda-Kosseh; David W Dempster; Hua Zhou; Ralph Müller; Elliott Goff; Ivelisse Colon; Mariana Bucovsky; Julie Stubby; Thomas L Nickolas; Emily M Stein; Robert R Recker; Joan M Lappe; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2019-07-26       Impact factor: 6.741

9.  A case of teriparatide on pregnancy-induced osteoporosis.

Authors:  Seok Hong Lee; Moon-Ki Hong; Seung Won Park; Hyoung-Moo Park; Jaetaek Kim; Jihyun Ahn
Journal:  J Bone Metab       Date:  2013-11-18

10.  Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.

Authors:  I Kyvernitakis; T C Reuter; L Hellmeyer; O Hars; P Hadji
Journal:  Osteoporos Int       Date:  2017-09-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.